MRI & Clinical Predictive Factors of the Response to Arthrographic

Status Recruiting

Clinical Trial Summary

The purpose of this study is to identify clinical and MRI factors associated to a better response to arthrographic distension in patients with severe capsulitis.

Clinical Trial Description

Patients presenting to the physical medicine and rehabilitation department [tertiary care] of Cochin Hospital for severe adhesive capsulitis for whom first-line medical treatment is not effective. The first-line treatment including analgesic, NSAIDs and / or intra-articular infiltration of a corticosteroid derivative and multi-weekly physiotherapy These patients are integrated into a usual protocol (routine care) consisting of performing an MRI with intravenous injection of gadolinium to confirm the diagnostic and eliminated others causes of shoulder stiffness. IV gadolinium-enhanced MRI can increase the performance of the signal analysis changes of the Synovium and capsule in the Axillary Recess and Rotator interval as compared with unenhanced measures The treatment consists in one to three arthrographic distensions by physiological serum, xylocaine 1% and injection of an ampoule of corticosteroids (DIPROSTENE) associated with intensive (immediate mobilization, recovery of maximum amplitudes by the physiotherapist and on arthro-motor). The primary objective of arthrographic distension is the expansion and rupture of the glenohumeral capsule in the subscapularis recess. It consists after local anesthesia, in an injection under pressure of air or liquid - opacifier or physiological serum - in the glenohumeral joint associated with an infiltration of cortisone derivatives at the end of the operation. Physical treatment aimed at rapid amplitude gain is started immediately after the arthrographic distension, under the effect of local anesthesia. It is at best continued daily at a rate of 2 to 8 hours per day for one to 2 weeks. Depending on the effect obtained on pain and the daily progression of rehabilitation, arthro-distension may be repeated once or twice during the mobilization period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04653636
Study type	Observational
Source	Assistance Publique - Hôpitaux de Paris
Contact	Marie-Martine LEFEVRE-COLAU, MD, PhD
Phone	630480893
Email	marie-martine.lefevre-colau@aphp.fr
Status	Recruiting
Phase
Start date	October 10, 2020
Completion date	November 23, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03245476` - Education-based Physical Therapy Approach for Adhesive Capsulitis	N/A
Recruiting	`NCT03462420` - Physiotherapy Program for Managing Adhesive Capsulitis in Patients With Diabetes	N/A
Recruiting	`NCT06181461` - Gong's Versus Kaltenborn Mobilization on Pain, Range of Motion and Function in Adhesive Capsulitis	N/A
Completed	`NCT03678038` - Comparison of Rotator Interval Injection Versus Intraarticular Hydrodilatation in Frozen Shoulder	N/A
Completed	`NCT01458691` - Intra-articular Injection of Allogeneic Platelet Rich Plasma (PRP) for Adhesive Capsulitis	N/A
Recruiting	`NCT01449227` - Natural Course of Adhesive Capsulitis of Hip	N/A
Terminated	`NCT00875862` - Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks	Phase 4
Completed	`NCT05402540` - Effectiveness of SCS Technique Verses ART in Adhesive Capsulitis	N/A
Completed	`NCT05398588` - Spencer's Muscle Energy Technique and Cyriax Deep Friction Massage on Adhesive Capsulitis	N/A
Recruiting	`NCT03676829` - Embolization for the Treatment of Pain Secondary to Adhesive Capsulitis	Phase 1/Phase 2
Recruiting	`NCT06019780` - Effects of Blood Flow Restriction Training in Patients With Adhesive Capsulitis	N/A
Completed	`NCT06062654` - Ultrasound-guided Hydrodistension in Patients With Adhesive Capsulitis	N/A
Completed	`NCT05897866` - Sayed Issa's Hybrid Shoulder Arthroscopic-Open Surgical Management (HSSM)	N/A
Completed	`NCT04822324` - Spencer's Muscle Energy Technique Along With Strain Counter Strain in Adhesive Capsulitis.	N/A
Recruiting	`NCT06041282` - Conservative Treatment of Early Adhesive Capsulitis	N/A
Withdrawn	`NCT03770546` - Amnion-Based Injections in the Shoulder	N/A
Completed	`NCT06064396` - Effects of Gong's Mobilization With and Without Stecco Fascial Therapy in Patients With Adhesive Capsulitis	N/A
Completed	`NCT04852939` - Bowen's Technique in Patients With Adhesive Capsulitis	N/A
Completed	`NCT05655611` - Muscle Energy Technique With Or Without First Rib Mobilization In Adhesive Capsulitis	N/A
Terminated	`NCT04160091` - Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

MRI and Clinical Predictive Factors of the Response to Arthrographic Distension in Severe Capsulitis — IRCAP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms